ArticleFrontiers in tuberculosis2025
Patterns of
Article in Frontiers in tuberculosis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Genotypic diversity of multi- and extensively drug-resistant Mycobacterium tuberculosis in Iran: a systematic review and meta-analysis.BMC infectious diseases · 2025Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Nearly half of new tuberculosis patients in Sverdlovsk Oblast were diagnosed with multidrug-resistant tuberculosis (MDR-TB) and often exhibited fluoroquinolone resistance (FQ-R). This study aimed to (1) determine the number of MDR-TB patients who had Materials and methods: We analyzed 345 MDR-TB DNA samples from patients with pulmonary TB in Sverdlovsk Oblast between 2017 and 2020 using the TB-TEST. We assumed that isolates with unique patterns, which were seen in only one patient, indicated minimal transmission of Results: In total, 174 distinct genetic patterns were identified: Group 1 included unique patterns, accounting for 36.8%; Group 2 included low-frequency patterns, accounting for 31.0%; and Group 3 included high-frequency patterns, accounting for 32.2%. The Beijing B0/W148 genotype was found in 72.4% of cases, and it was significantly less frequent in patients with unique patterns (59.1% vs. 66.4% vs. 93.7%). Mutations in Conclusion: Patients with unique patterns were found to have MDR-TB. However, a higher proportion of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.